Results 191 to 200 of about 269,159 (265)
Cost-effectiveness of an oral cholate challenge test for the management of patients at risk for large esophageal varices. [PDF]
Chavan S +3 more
europepmc +1 more source
Percutaneous transhepatic embolization of gastro-esophageal varices for the treatment of variceal bleeding in portal vein thrombosis secondary to hepatocellular carcinoma: A case report. [PDF]
Rathod AS, Banode P.
europepmc +1 more source
openaire +1 more source
Thrombocytopenia and Grading of Esophageal Varices in Patients With Chronic Liver Disease. [PDF]
Abbas MA +7 more
europepmc +1 more source
Role of Spleen Stiffness Measurements with 2D Shear-Wave Elastography for Esophageal Varices in Patients with Compensated Advanced Chronic Liver Disease. [PDF]
Muzica C +12 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Endoscopic Treatment of Esophageal Varices.
Clinical Liver Disease, 2021Acute variceal bleeding is a complication of portal hypertension, usually due to cirrhosis, with high morbidity and mortality. There are 3 scenarios for endoscopic treatment of esophageal varices: prevention of first variceal bleed, treatment of active ...
M. Zuckerman +2 more
semanticscholar +1 more source
Journal of Evidence-Based Medicine, 2020
All patients with liver cirrhosis and portal hypertension should be stratified by risk groups to individualize different therapeutic strategies to increase the effectiveness of treatment. In this regard, the development of primary prophylaxis of variceal
D. Garbuzenko, N. Arefyev
semanticscholar +1 more source
All patients with liver cirrhosis and portal hypertension should be stratified by risk groups to individualize different therapeutic strategies to increase the effectiveness of treatment. In this regard, the development of primary prophylaxis of variceal
D. Garbuzenko, N. Arefyev
semanticscholar +1 more source
Journal of Hepatology, 2019
BACKGROUND & AIMS Non-selective beta-blockers (NSBBs) are the mainstay of primary prophylaxis of esophageal variceal bleeding in patients with liver cirrhosis. We investigated whether non-invasive markers of portal hypertension correlate with hemodynamic
Hwi-Young Kim +8 more
semanticscholar +1 more source
BACKGROUND & AIMS Non-selective beta-blockers (NSBBs) are the mainstay of primary prophylaxis of esophageal variceal bleeding in patients with liver cirrhosis. We investigated whether non-invasive markers of portal hypertension correlate with hemodynamic
Hwi-Young Kim +8 more
semanticscholar +1 more source

